Four years ago, a record number of biotechnology companies flooded public markets, capitalizing on investor interest in drugmakers amid the …
Pharma Newswire™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC
Category:
Clinical
-
-
Abselion has appointed Dale Gordon as Chair of the Board of Directors Abselion has announced the appointment of Dale Gordon as Chair of the Board …
-
Clinical
Can a multibillion-dollar deal put Pfizer in the obesity big leagues?
by Newsroomby NewsroomCan a multibillion-dollar deal put Pfizer in the obesity big leagues? Source link
-
Laigo Bio has completed the second close of its seed financing round at €5.5m, bringing the total raised to €17m …
-
Is pharma’s IRA pricing battle running out of steam? Source link
-
Clinical
Arvinas reports strong phase 1 results for ARV-102 in Parkinson’s disease
by Newsroomby NewsroomEarly trial shows more than 50% LRRK2 reduction and supports expansion into other neurodegenerative conditions Arvinas has announced encouraging phase …
-
Clinical
As obesity M&A heats up, pharmas could get ‘blinded by opportunity’
by Newsroomby NewsroomGLP-1 drugs are already a multibillion-dollar market, yet untapped opportunities are fueling deal-making as companies look for a competitive edge …
-
Regulator authorises deuruxolitinib for adults with extensive hair loss The MHRA has approved deuruxolitinib, marketed as Leqselvi, for the treatment …
-
Clinical
Will the first fibromyalgia drug in 15 years deliver a breakthrough in pain?
by Newsroomby NewsroomThis summer’s approval of Tonix Pharmaceuticals’ fibromyalgia drug, Tonmya, ended a 15-year dry spell in a market long beset by …
-
Nucleome has appointed Dr Michelle Morrow as CSO Nucleome Therapeutics, a company tackling the molecular causes of inflammatory diseases through a …